We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
UnitedHealth Group (UNH) Dips More Than Broader Market: What You Should Know
Read MoreHide Full Article
UnitedHealth Group (UNH - Free Report) closed at $367.08 in the latest trading session, marking a -2.1% move from the prior day. The stock trailed the S&P 500, which registered a daily loss of 0.25%. Elsewhere, the Dow lost 0.86%, while the tech-heavy Nasdaq added 0.24%.
Heading into today, shares of the largest U.S. health insurer had lost 5.39% over the past month, lagging the Medical sector's loss of 1.01% and the S&P 500's loss of 0.42%.
The investment community will be paying close attention to the earnings performance of UnitedHealth Group in its upcoming release. The company is slated to reveal its earnings on October 13, 2026. The company is expected to report EPS of $4.12, up 41.1% from the prior-year quarter. In the meantime, our current consensus estimate forecasts the revenue to be $111.38 billion, indicating a 1.57% decline compared to the corresponding quarter of the prior year.
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $19.85 per share and revenue of $446.78 billion. These totals would mark changes of +21.41% and -0.18%, respectively, from last year.
It's also important for investors to be aware of any recent modifications to analyst estimates for UnitedHealth Group. Such recent modifications usually signify the changing landscape of near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the business outlook.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. The Zacks Consensus EPS estimate has moved 0.15% higher within the past month. UnitedHealth Group is currently sporting a Zacks Rank of #2 (Buy).
Valuation is also important, so investors should note that UnitedHealth Group has a Forward P/E ratio of 18.89 right now. This valuation marks a discount compared to its industry average Forward P/E of 21.95.
We can also see that UNH currently has a PEG ratio of 1.41. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. As of the close of trade yesterday, the Medical - HMOs industry held an average PEG ratio of 1.41.
The Medical - HMOs industry is part of the Medical sector. Currently, this industry holds a Zacks Industry Rank of 29, positioning it in the top 12% of all 250+ industries.
The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.
View the Zacks #1 Rank List
Image: Bigstock
UnitedHealth Group (UNH) Dips More Than Broader Market: What You Should Know
UnitedHealth Group (UNH - Free Report) closed at $367.08 in the latest trading session, marking a -2.1% move from the prior day. The stock trailed the S&P 500, which registered a daily loss of 0.25%. Elsewhere, the Dow lost 0.86%, while the tech-heavy Nasdaq added 0.24%.
Heading into today, shares of the largest U.S. health insurer had lost 5.39% over the past month, lagging the Medical sector's loss of 1.01% and the S&P 500's loss of 0.42%.
The investment community will be paying close attention to the earnings performance of UnitedHealth Group in its upcoming release. The company is slated to reveal its earnings on October 13, 2026. The company is expected to report EPS of $4.12, up 41.1% from the prior-year quarter. In the meantime, our current consensus estimate forecasts the revenue to be $111.38 billion, indicating a 1.57% decline compared to the corresponding quarter of the prior year.
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $19.85 per share and revenue of $446.78 billion. These totals would mark changes of +21.41% and -0.18%, respectively, from last year.
It's also important for investors to be aware of any recent modifications to analyst estimates for UnitedHealth Group. Such recent modifications usually signify the changing landscape of near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the business outlook.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. The Zacks Consensus EPS estimate has moved 0.15% higher within the past month. UnitedHealth Group is currently sporting a Zacks Rank of #2 (Buy).
Valuation is also important, so investors should note that UnitedHealth Group has a Forward P/E ratio of 18.89 right now. This valuation marks a discount compared to its industry average Forward P/E of 21.95.
We can also see that UNH currently has a PEG ratio of 1.41. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. As of the close of trade yesterday, the Medical - HMOs industry held an average PEG ratio of 1.41.
The Medical - HMOs industry is part of the Medical sector. Currently, this industry holds a Zacks Industry Rank of 29, positioning it in the top 12% of all 250+ industries.
The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.